Empowering Young Adults in Cancer Care: How a New Decision-Making Tool is Changing the Game
"A groundbreaking approach to quantifying patient preferences promises to reshape treatment decisions and improve end-of-life care for young adults facing cancer."
Cancer remains a formidable adversary, particularly for adolescents and young adults (AYAs). Despite advancements in treatment, it remains a leading cause of non-accidental death in this age group. What's more, AYA oncology patients often receive more intensive medical services at the end of life (EOL) compared to younger children and older adults. This highlights a critical need: ensuring that the care provided aligns with their values and preferences.
EOL decision-making is a research priority, largely due to a lack of evidence-based tools that can guide healthcare providers (HCPs) and support patients and families through these challenging times. The complexities of oncology decision-making, compounded by uncertainties about prognosis and the rapid pace of treatment innovations, make it difficult for AYA patients and their parents to navigate the available options.
A groundbreaking study is working to address these challenges by developing a novel tool that quantifies the relative importance of various factors considered by AYA patients, their parents, and healthcare providers when making treatment choices. This approach aims to empower patients, improve communication, and ultimately lead to more goal-concordant care and a reduction in overly intensive EOL interventions.
Defining a Distinct Patient Population
The National Cancer Institute defines adolescent and young adult (AYA) oncology as cancer care or research focused on those diagnosed with cancer between the ages of 15 and 39. A cancer diagnosis during this stage of life brings unique clinical and psychosocial challenges that differ from those faced by older adults. These patients must often manage treatment while navigating education, careers, and early adult relationships.
Holistic Programs as the Standard Model
Established AYA cancer programs, such as AYA@USC housed in the USC Norris Comprehensive Cancer Center, aim to improve health outcomes and quality of life through holistic care, education, research, and community building. The Mass General AYA Cancer Program was founded to help young patients navigate their care while also balancing the social demands of young adult life. Even with these programs in place, decision-making support for younger patients remains an evolving area of care.
Building a Foundation for AYA Care
Specialized adolescent and young adult oncology emerged as a distinct field, with the National Cancer Institute formally defining the population as patients diagnosed between ages 15 and 39. Dedicated programs, including the Mass General AYA Cancer Program, were founded to help young patients navigate their care while balancing the challenges that accompany a young adult diagnosis. These programs represent a milestone in recognizing that younger patients need age-specific approaches to treatment and support.
The Conjoint Analysis Revolution: Putting Patient Preferences First
The core of this innovative approach lies in conjoint analysis, a powerful method for understanding how individuals value different attributes of a product or service. In this context, the 'product' is cancer treatment, and the 'attributes' are factors like quality of life, potential side effects, the possibility of a cure, and survival length. Unlike traditional methods that focus on one attribute at a time, conjoint analysis allows for the simultaneous consideration of multiple factors, mirroring the complexity of real-world decisions.
- Comprehensive Assessment: Conjoint analysis considers multiple treatment attributes simultaneously, reflecting the complexity of real-world decisions.
- Preference Quantification: The methodology quantifies the relative importance of each attribute, providing valuable insights into patient priorities.
- Enhanced Communication: The tool facilitates communication between patients, families, and healthcare providers.
- Goal-Concordant Care: The aim is to align treatment decisions with patient preferences, leading to more personalized and effective care.
Testing Decision Aids in Practice
Researchers are studying decision-making tools, commonly called 'decision aids' in health care, to see whether they improve outcomes for the people who use them. A Duke Health study examined a treatment guide used by families overseeing the care of life-support patients. The study assessed whether the tool eased anxiety, depression, or post-traumatic stress for the decision-makers.
When Tools Fall Short
Evidence also highlights the limits of decision-support tools. In the Duke Health study, the treatment guide did not ease symptoms of depression, anxiety, or post-traumatic stress for the decision-makers as they oversaw their loved one's care. This underscores that a decision aid alone may be insufficient without broader psychosocial support, a finding that has direct relevance to young adult cancer care.
Comparing Program Models Across Institutions
Different institutions have tailored their AYA programs to the same population in distinct ways. William Osler Health System designed its AYA Cancer Care Program specifically for patients aged 18 to 39, recognizing the unique clinical and psychosocial challenges of a cancer diagnosis at that life stage. AYA@USC focuses on holistic care, education, research, and community building, while the Mass General AYA Cancer Program emphasizes helping patients balance care with the demands of young adult life.
Looking Ahead: Empowering a Vulnerable Population
The MyPref tool represents a significant step forward in empowering AYA patients, their families, and their healthcare providers to make more informed and preference-aligned treatment decisions. By providing a structured way to clarify and communicate values, this approach has the potential to transform the landscape of AYA oncology care, ensuring that these young adults receive the support and respect they deserve during their most challenging times.
Expert Consensus on Integrated Support
Across institutions, experts converge on the need for support that goes beyond medical treatment. Programs such as AYA@USC emphasize holistic care, education, research, and community building to improve health outcomes and quality of life. The emphasis on social connection reflects a growing recognition that emotional and practical support is as important as the clinical plan.
Toward Age-Specific, Evidence-Based Tools
Ongoing research from the National Cancer Institute addresses treatment, follow-up care, coping, and related research for adolescents and young adults with cancer. As more evidence accumulates, decision-making tools will likely need to be tailored to the unique circumstances of younger patients rather than adapted from tools built for other populations. Integrating follow-up care and long-term coping support will be central to the next generation of AYA decision aids.
Systemic Gaps for a Neglected Age Group
Young adults with cancer face a set of unique challenges that the broader health system has been slow to address. Social connection is just one of those challenges, and AYA programs were created to help young patients navigate their care while balancing the other demands of young adult life. Sustaining these programs and making decision tools accessible to all patients remain systemic hurdles.
The Human Side of the Diagnosis
Behind the clinical statistics are young people managing treatment alongside school, work, and relationships. The Mass General AYA Cancer Program was founded specifically to help young patients navigate their care while maintaining social connection when it counts most. Programs like these aim to make the experience less isolating for a group whose lives are still taking shape.